Fulcrum Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.

About FULC

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. 

CEO
Alexander C. Sapir
CEOAlexander C. Sapir
Employees
55
Employees55
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
55
Employees55

FULC Key Statistics

Market cap
282.68M
Market cap282.68M
Price-Earnings ratio
-3.05
Price-Earnings ratio-3.05
Dividend yield
—
Dividend yield—
Average volume
1.48M
Average volume1.48M
High today
$3.72
High today$3.72
Low today
$3.66
Low today$3.66
Open price
$3.67
Open price$3.67
Volume
1.18M
Volume1.18M
52 Week high
$15.74
52 Week high$15.74
52 Week low
$2.83
52 Week low$2.83

Stock Snapshot

The current Fulcrum Therapeutics(FULC) stock price is $3.70, with a market capitalization of 282.68M. The stock trades at a price-to-earnings (P/E) ratio of -3.05.

On 2026-10-20, Fulcrum Therapeutics(FULC) stock moved within a range of $3.66 to $3.72. With shares now at $3.70, the stock is trading +1.1% above its intraday low and -0.5% below the session's peak.

Trading activity shows a volume of 1.18M, compared to an average daily volume of 1.48M.

Over the past 52 weeks, Fulcrum Therapeutics(FULC) stock has traded between a high of $15.74 and a low of $2.83.

Over the past 52 weeks, Fulcrum Therapeutics(FULC) stock has traded between a high of $15.74 and a low of $2.83.

People also own

Based on the portfolios of people who own FULC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.